Diagnostic work-up and outcome of cervical metastases from an unknown primary

Conclusions. An intensive diagnostic work-up including 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) detects many unknown primary tumours, leads to a low emergence rate of primary tumours, and selects carcinoma of unknown primary with much more favourable results after neck dissection and postoperative radiotherapy. Objective. To investigate the optimal diagnostic approach and best treatment modality for rare head and neck cancer of unknown primary. Patients and methods. In a retrospective study, 69 patients admitted from 1987 to 2002 with cervical lymph node metastases without apparent primary were reviewed. Test characteristics of all diagnostic procedures were calculated. Disease-free and overall survival rates were calculated. Major prognostic factors were analysed univariately. Results. At the primary site FDG-PET showed the best sensitivity with 69% and the highest negative predictive value with 87%. Computed tomography and magnetic resonance imaging had a better specificity with 87% and 95%, respectively. The primary tumour was detected in 23 cases (33%). Frequent primary tumour origin was the palatine tonsil (n=8, 35%), base of the tongue (n=6, 26%) and lung (n=4, 17%). All patients with unknown primary were treated by neck dissection. Adjuvant radiotherapy was performed in 26 patients (57%), concurrent radiochemotherapy was performed in 12 patients (26%). The primary emergence rate was 7%. The 5-year overall survival rate was inferior in patients with detected primary in comparison with patients with unknown primary (22% versus 52%). Significant prognostic factors in case of unknown primary were M stage, smoking, alcohol consumption and tonsillectomy. Radiotherapy but not chemotherapy with carboplatin influenced the overall survival.

[1]  M. Dietlein,et al.  18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases , 2004, Nuklearmedizin.

[2]  J. Jassem,et al.  Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. , 2004, Cancer treatment reviews.

[3]  W. Wong,et al.  The impact of FDG PET on the management of occult primary head and neck tumours. , 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  E. Vokes,et al.  Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  K. Pitman,et al.  Management of unknown primary tumor , 2003, Head & neck.

[6]  W. Issing,et al.  Diagnosis and management of carcinoma of unknown primary in the head and neck , 2003, European Archives of Oto-Rhino-Laryngology.

[7]  J. Johansen,et al.  Implication of 18F‐Fluoro‐2‐Deoxy‐D‐Glucose Positron Emission Tomography on Management of Carcinoma of Unknown Primary in the Head and Neck: A Danish Cohort Study , 2002, The Laryngoscope.

[8]  P. Levine,et al.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. , 2002, Archives of otolaryngology--head & neck surgery.

[9]  R. Engers,et al.  Diagnostic strategies in cervical carcinoma of an unknown primary (CUP) , 2002, European Archives of Oto-Rhino-Laryngology.

[10]  C. O'brien,et al.  Unknown primary squamous cell carcinoma of the head and neck: a review of diagnosis, treatment and outcomes. , 2002, Asian journal of surgery.

[11]  I. Haas,et al.  Comments on the publication: Haas I. et al. (2001) The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 258: 177-183 , 2002, European Archives of Oto-Rhino-Laryngology.

[12]  A. Rao,et al.  Metastatic squamous cell carcinoma of the neck from an unknown primary: Management options and patterns of relapse , 2002, Head & neck.

[13]  K. Ang,et al.  Cervical lymph node metastases from occult squamous cell carcinoma , 2002, Current treatment options in oncology.

[14]  A. Mäkitie,et al.  Cervical Metastasis of Unknown Origin: A Series of 72 Patients , 2002, Acta oto-laryngologica.

[15]  D. Rades,et al.  Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  K. Ang,et al.  Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? , 2001, International journal of radiation oncology, biology, physics.

[17]  U. Pietrzyk,et al.  2[18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography is a Sensitive Tool for the Detection of Occult Primary Cancer (Carcinoma of Unknown Primary Syndrome) with Head and Neck Lymph Node Manifestation , 2000, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[18]  C. Grau,et al.  Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  M. Hanasono,et al.  Uses and limitations of fdg positron emission tomography in patients with head and neck cancer , 1999, The Laryngoscope.

[20]  H. Kashima,et al.  Clinical Evaluation of Patients With Metastatic Squamous Carcinoma of the Neck With Occult Primary Tumor , 1986, Southern medical journal.

[21]  R. G. Chambers,et al.  Metastases to lymph nodes of the head and neck from an unknown primary site. , 1977, American journal of surgery.

[22]  G. Fletcher,et al.  Cervical lymph node metastasis: Unknown primary cancer , 1973, Cancer.

[23]  R. Lindberg Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts , 1972, Cancer.

[24]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[25]  E. Cadman,et al.  An analysis of 1539 patients with cancer of unknown primary site , 1986, Cancer.